When should discontinuation of brigatinib be considered?

The timing of discontinuation of Brigatinib (Brigatinib) depends primarily on the patient's response to treatment and disease control. For most patients, treatment with brigatinib should be continued until the disease is significantly controlled or the desired treatment goals are achieved. When a patient's imaging results and biomarkers show stable disease or significant remission, doctors may evaluate whether the drug can be reduced or discontinued. However, in most cases, patients are recommended to continue taking brigatinib until their doctor confirms that their condition is stable.

Resistance to brigatinib may typically develop after 6 to 12 months of treatment. Once a patient develops drug resistance, the therapeutic effect will be weakened, and the drug may need to be changed or the treatment plan adjusted. If testing reveals resistance mutations, continued use of brigatinib may not achieve the desired effect, so the drug may need to be discontinued and other treatment options considered. The specific treatment strategy after discontinuation should be determined by the physician based on drug resistance and the patient's overall health.

Side effects of brigatinib can sometimes affect a patient's quality of life. If side effects are severe and difficult to control, your doctor may consider reducing the dose or discontinuing the medication. Symptomatic treatment and dose adjustment are often used when dealing with side effects. If side effects do not improve after adjustments, discontinuation may be an option. After stopping the medication, the doctor will develop a corresponding symptomatic treatment plan to help the patient regain health.

In some cases, changes in treatment may result in discontinuation of brigatinib . For example, depending on the progression of the disease and the doctor's evaluation, patients may need to switch to other types of treatment, such as immunotherapy or chemotherapy. Brigatinib may be stopped if your doctor decides on another treatment option. At the same time, the doctor will conduct a comprehensive assessment of the patient's condition to select the most appropriate alternative treatment.